MV,
How can one not question things ? Look below, what is soon ? This was put out June 2017 and now is April 2021.
Of course I suspect some of the company lovers will point out it says "anticipated", so not promised.
At some point one would hope the company would get something signifcant done. Seems so many getting there, getting there, almost there....then fizzle experiences.
Where is any recent news on N-Assay and what is the "anticipated" happening going be now ?
"June 5, 2017
Reception of the NanoLogix N-Assay Bacteria Diagnostic Technology Poster for E. coli Presented at the American Society for Microbiology (ASM Microbe) Annual meeting
Novel Rapid Immunoassay for Simultaneous Identification and Determination of Antibiotic Susceptibility of E. coli O157:H7
Jonathan Faro, MD, PhD and Sebastian Faro, MD, PhD, medical researchers presenting the technology poster at the ASM Annual meeting in New Orleans this past weekend stated:
"ASM Microbe was a very stimulating meeting. We enjoyed meeting many investigators and the engaging discussions that followed. Of the many rapid ID tests either on the market or the many more that presented and will soon be available, our assay is the most unique, and has the ability to provide the greatest limit of detection while simultaneously determining antibiotic susceptibility."
Further information from NanoLogix metrics monitoring indicated interest from at least two major laboratories.
The N-Assay is currently undergoing development for rapid detection of Urinary Tract Infections (UTI) and we anticipate the N-Assay to be debuted soon as the definitive UTI test for speed, accuracy, and sensitivity.
